Unknown

Dataset Information

Outcomes of patients with myelodysplatic syndrome and chronic myelomonocytic leukemia post clofarabine failure.


ABSTRACT:

Background

The outcome of patients with myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) post clofarabine is unknown.

Methods

We reviewed 109 patients with MDS or CMML with a median age of 67 years, treated with a clofarabine-based chemotherapy as frontline (n = 38) or salvage (n = 71) therapy. A total of 58 (53%) patients received salvage therapy after clofarabine failure: 13 allogeneic stem cell transplant (ASCT), 18 high-dose cytarabine-containing regimen, 10 hypomethylating agents and 17 investigational treatments.

Results

Eight patients achieved complete remission (CR) and three had stable disease for an overall response rate of 19%. With a median follow-up of 3 months from clofarabine failure, 12 patients (11%) remained alive, 5 remain i

SUBMITTER: Ghanem H 

PROVIDER: S-EPMC3949300 | biostudies-literature | 2014 Apr

REPOSITORIES: biostudies-literature